TABLE 4.
Median (interquartile range) values of bone markers at baseline and after 12 weeks on modified Atkins diet in 53 patients divided according to median age 37 years, and 51 patients divided according to median BMI 25.82 kg/m²
Age, n = 53 | BMI, n = 51 | |||
---|---|---|---|---|
<37 years, n = 26 | ≥37 years, n = 27 | <25.8 kg/m², n = 25 | ≥25.8 kg/m², n = 26 | |
PTH, pmol·L–1 | ||||
Baseline | 4.04 (2.99) | 5.04 (3.75) | 3.96 (2.86) | 5.11 (3.22) |
12 weeks | 3.43 (2.50) | 4.55 (2.79) | 4.12 (2.65) | 4.24 (2.07) |
p | <.01 | .05 | .96 | <.01 |
Ca, nmol·L–1 | ||||
Baseline | 1.25 (.06) | 1.23 (.06) | 1.25 (.07) | 1.36 (.06) |
12 weeks | 1.26 (.07) | 1.22 (.05) | 1.22 (.04) | 1.22 (.05) |
p | .01 | .09 | .04 | .01 |
25‐OH vit D, nmol·L–1 | ||||
Baseline | 55.50 (26) | 65 (30) | 71 (40) | 59 (25) |
12 weeks | 77 (34) | 67.50 (26) | 80 (28) | 65 (30) |
p | <.01 | .24 | .06 | .02 |
1,25‐OH vit D, nmol·L–1 |
n = 25 | n = 27 | ||
Baseline | 103 (61.50) | 95.00 (41) | 88.00 (62) | 100 (46) |
12 weeks | 84 (63) | 93.00 (38) | 83.00 (49.50) | 93 (51) |
p | <.23 | .05 | <.01 | .55 |
Ph, mmol·L–1 | ||||
Baseline | 1.10 (.20) | 1.10 (.20) | 1.10 (.20) | 1.10 (.25) |
12 weeks | 1.20 (.10) | 1.20 (.30) | 1.20 (.25) | 1.20 (.20) |
p | .24 | .12 | .16 | .17 |
ALP, U/L | ||||
Baseline | 57 (45) | 67 (32) | 65 (39) | 70 (43) |
12 weeks | 64 (42) | 64 (27) | 59 (36) | 64 (41) |
p | .42 | .12 | .44 | .09 |
CTX−1, µg/L | ||||
Baseline | .56 (.40) | .37 (.28) | .51 (.36) | .40 (.30) |
12 weeks | .49 (.26) | .32 (.27) | .47 (.41) | .33 (.21) |
p | .09 | .12 | .32 | .02 |
P1NP, µg/L | ||||
Baseline | 52.97 (40.35) | 53 (24.80) | 54 (34.56) | 47.76 (24.85) |
12 weeks | 41.86 (37.67) | 44 (34.29) | 45.43 (39.11) | 41.21 (26.83) |
p | <.001 | .07 | <.01 | .03 |
Abbreviations: 1,25‐OH vit D, 1,25‐OH vitamin D; 25‐OH vit D, 25‐OH vitamin D; ALP, alkaline phosphatase; BMI, body mass index; Ca, calcium; CTX‐1, C‐terminal telopeptide collagen type 1; P1NP, procollagen type 1 N‐terminal propeptide; Ph, phosphate; PTH, parathyroid hormone.